536 related articles for article (PubMed ID: 31103408)
1. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
3. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
5. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract][Full Text] [Related]
6. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
[TBL] [Abstract][Full Text] [Related]
7. Microarray-based measurement of microRNA-449c-5p levels in hepatocellular carcinoma and bioinformatic analysis of potential signaling pathways.
Jiang L; Wu CL; Wu JZ; Yang X; Wang HL; Li GJ
Pathol Res Pract; 2019 Jan; 215(1):68-81. PubMed ID: 30389318
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance of decreased miR-125b-5p in hepatocellular carcinoma: evidence based on RT-qPCR, microRNA-microarray, and microRNA-sequencing.
Guo YN; Dong H; Ma FC; Huang JJ; Liang KZ; Peng JL; Chen G; Wei KL
Int J Clin Exp Pathol; 2019; 12(1):21-39. PubMed ID: 31933718
[TBL] [Abstract][Full Text] [Related]
9. Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.
Luo YH; Tang W; Zhang X; Tan Z; Guo WL; Zhao N; Pang SM; Dang YW; Rong MH; Cao J
Medicine (Baltimore); 2017 Jul; 96(30):e7545. PubMed ID: 28746200
[TBL] [Abstract][Full Text] [Related]
10. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
Lin XQ; Huang ZM; Chen X; Wu F; Wu W
Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
Pan WY; Zeng JH; Wen DY; Wang JY; Wang PP; Chen G; Feng ZB
Oncol Lett; 2019 Feb; 17(2):1695-1713. PubMed ID: 30675229
[TBL] [Abstract][Full Text] [Related]
13. Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.
Li MF; Zeng JJ; Pan AP; Lin YH; Lin HS; Zhang RZ; Yang L; Zhang Y; Dang YW; Chen G
Med Sci Monit; 2018 Jul; 24():4914-4925. PubMed ID: 30007991
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
[TBL] [Abstract][Full Text] [Related]
15. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
16. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-139-5p negatively regulates NME1 expression in hepatocellular carcinoma cells.
Yang J; Li Z; Pang Y; Zhou T; Sun J; Cheng XY; Zheng WV
Adv Clin Exp Med; 2022 Jun; 31(6):655-670. PubMed ID: 35438846
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
Shen Q; Cicinnati VR; Zhang X; Iacob S; Weber F; Sotiropoulos GC; Radtke A; Lu M; Paul A; Gerken G; Beckebaum S
Mol Cancer; 2010 Aug; 9():227. PubMed ID: 20799954
[TBL] [Abstract][Full Text] [Related]
19. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
Wang JT; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
